Johnson & Johnson ordered to pay $40 million in baby powder cancer case
A California jury ordered Johnson & Johnson to pay $40 million to two women who claimed its talc-based baby powder caused their ovarian cancer. The women testified that decades of use led to major surgeries and chemotherapy. Johnson & Johnson plans to appeal, stating the verdict is aberrant and lacks evidence.
A California jury ordered Johnson & Johnson to pay $40 million to two women who claimed its talc-based baby powder caused their ovarian cancer. The women testified that decades of use led to major surgeries and chemotherapy. Johnson & Johnson plans to appeal, stating the verdict is aberrant and lacks evidence.
